Apoptotic MSCs and MSC-Derived Apoptotic Bodies as New Therapeutic Tools

Irina V Kholodenko1, Roman V Kholodenko2, Alexander G Majouga3

  • 1Laboratory of Cell Biology, Orekhovich Institute of Biomedical Chemistry, 119121 Moscow, Russia.

Insights

Mesenchymal stem cells (MSCs) show therapeutic promise, but mechanisms remain unclear. Apoptotic MSCs and their derived bodies mediate effects via efferocytosis, offering insights into MSC therapy.

Area of Science:

  • Regenerative Medicine
  • Immunology
  • Cell Biology

Background:

  • Mesenchymal stem cells (MSCs) demonstrate therapeutic potential in preclinical and clinical studies.
  • The precise mechanisms driving MSC therapeutic efficacy and regenerative potential are not fully understood.
  • Transplanted MSCs can undergo apoptosis and clearance while retaining therapeutic effects, particularly immunomodulation.

Purpose of the Study:

  • To review recent data on apoptotic MSCs and MSC-derived apoptotic bodies (MSC-ApoBDs).
  • To explore the functions and therapeutic mechanisms of apoptotic MSCs and MSC-ApoBDs.
  • To discuss MSC-generated extracellular vesicles involved in therapeutic functions.

Main Methods:

  • Concise review of existing literature.
  • Focus on recent findings regarding apoptotic MSCs and MSC-ApoBDs.
  • Analysis of efferocytosis as a mechanism for MSC therapeutic effects.

Main Results:

  • Apoptotic MSCs and MSC-ApoBDs can mediate therapeutic effects, especially immunomodulatory ones.
  • Efferocytosis of apoptotic MSCs by host phagocytic cells is a key mechanism.
  • MSC-derived extracellular vesicles, including apoptotic bodies, are crucial for therapeutic functions.

Conclusions:

  • Apoptotic MSCs and their derived extracellular vesicles, particularly MSC-ApoBDs, play a significant role in MSC-based therapy.
  • Understanding efferocytosis and vesicle-mediated mechanisms is vital for optimizing MSC therapeutic strategies.
  • Further research into these mechanisms can enhance the predictability and efficacy of MSC treatments.

Related Concept Videos

Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.9K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.5K
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized...
3.9K